期刊文献+

生长抑素抑制人类肝癌细胞株HepG2生长的机制及对p16基因表达水平的影响

The effects of somatostatin on the proliferation of human HepG2 cells and the level of gene p16
原文传递
导出
摘要 目的探讨生长抑素(SST)抑制人类肝癌细胞株生长的机制及对p16基因表达水平的影响。方法取液氮保存的人类肝癌细胞株HepG2培养后,随机分为三组:对照组(A组)不含SST、低浓度组(B组)SST为10^-8mol/L、高浓度组(C组)SST为10^-5mol/L,用流式细胞术(FCM)检测细胞周期,RT.PCR法检测p16基因mRNA表达变化。结果HepG2经不同浓度SST作用24h后FCM检测细胞周期发现,A组、B组、c组G。期细胞所占比例均值分别为(51.41±3.27)%、(65.43±3.41)%、(69.02±3.75)%,而s期细胞所占比例均值为(36.86±2.31)%、(20.34±2.52)%、(18.50±3.09)%,G2期细胞所占比例均值为(11.46±1.96)%、(14.23±3.83)%、(12.48±3.18)%。与A组相比,B组、c组Gt期细胞明显增多,而s期细胞相对减少。经RT—PCR法检测,各组均表达p16基因mRNA,但B组、C组表达明显增强。结论SST对人类肝癌细胞的抑制可能是通过提高p16基因表达而发挥作用的。 Objective To study the effect of somatostatin on the Proliferation in Human HepG2 Cells and the Level of Gene p16. Methods The cell line HepG2 were divided into 3 groups: control groupA, low concentration group B and high concentration group C. The flow cytometry (FCM) was used to detect phase distribution of the cycles and detect the expression of p16 gene by using RT-PCR. Results Human HepG2 cells affected 24 hours later by different density SST, using FCM, we discovered that the G1 cell cycles of each A group, B group, C group occupied the proportion respectively is (51.41±3.27)%, (65.43±3.41)%, (69.02± 3.75)%, that the S cell cycles is (36.86±2.31)%, (20.34±2.52)%, (18.50±3.09)%, that the G2 cell cycles is (11.46±1.96)%, (14.23±3.83)%, (12.48±3.18)%. Compare to the control groupA, the G1 cell cycles of groupB and group C were increased obviously. But the S cell cycles relatively reduced. The levels of p16 gene were expressed in each group detected by RT-PCR, but B group and C group expressed obviously. Conclusion The inhibited mechanism of somatostatin for HepG2 was expressed probably by improving levels of p16.
出处 《肿瘤研究与临床》 CAS 2010年第11期758-760,共3页 Cancer Research and Clinic
关键词 生长抑素 基因 P16 细胞周期 肝肿瘤 Somatostatin Genes, p16 Cell cycle Liver neoplasms
  • 相关文献

参考文献6

  • 1罗中华,孙立军,贺洪德,李敬邦,张学昕,刘舰.肝细胞生长因子体外对肝癌细胞HepG2增殖和凋亡的影响[J].第四军医大学学报,2006,27(8):717-719. 被引量:7
  • 2程天明,袁爱力.生长抑素及其类似物的研究进展[J].国外医学(肿瘤学分册),1998,25(5):265-268. 被引量:9
  • 3Evers BM,Parekh E,Townsend CM Jr,et al.Somatostatin and analogues in the treatment of cancer.Ann Surg,1991,213:190-198.
  • 4Bousquet C,Delesque N,Lopez F,et al.SST2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphates SHP-1.J Biol Chem,1998,273:7099-7106.
  • 5Sharma K,Patel YC,Srikant CB.C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest.Mol Endocrinol,1999,13:82-90.
  • 6Remacle-Bonnet M,Garrouste FL,Heller S,et al.Insulin-like growth factor-1 protects colon cells from death factor-induced apoptosis by protention tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.Cancer Res,2000,60:2007-2017.

二级参考文献5

  • 1Jiang WG.Martin TA,Parr C,et al.Hepatocyte growth factor,its receptor,and their potential value in cancer therapies[J].Crit Rev Oncol Hematol,2005,53(1):35-69.
  • 2Parr C,Jiang WG.Expression of hepatocyte growth factor/scatter factor,its artivator inhition and the c-Met receptor in hum cancer cells[J].Int J Oncol,2001,19(4):857-863.
  • 3Lee HS,Huang AM,Huang GT,et al.Hepatocyte growth faetor stimulates the growth and activates mitogen-activated protein kinase in human cells[J].J Biomed Sit,1998,5(3):180-184.
  • 4Santoni Rugiu E.Preisegger KH,Kiss A,et al.Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model[J].PNAS,1996,93:9577-9582.
  • 5Kristina Cole,Elise Kohn. Calcium-mediated signal transduction: biology, biochemistry, and therapy[J] 1994,Cancer and Metastasis Reviews(1):31~44

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部